MAM
LLY icon

Magellan Asset Management’s Eli Lilly LLY Stock Holding History

Magellan Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-980
Closed -$868K – 101
2024
Q3 		$868K Sell
980
-4
-0.4% -$3.6K 0.01% 85
2024
Q2 		$891K Sell
984
-166
-14% -$133K 0.01% 87
2024
Q1 		$895K Buy
+1,150
New +$818K 0.01% 85
2018
Q3 		– Sell
-299
Closed -$26K – 75
2018
Q2 		$26K Hold
299
– – ﹤0.01% 68
2018
Q1 		$23K Buy
299
+39
+15% +$3.14K ﹤0.01% 69
2017
Q4 		$22K Buy
+260
New +$22.1K ﹤0.01% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Magellan Asset Management's LLY Position: Q4 2024 in Review

Magellan Asset Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 980 shares — an estimated $868K sold.

Magellan Asset Management first reported a position in LLY in Q4 2017 and held it in 6 quarters. The position peaked at $895K in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Magellan Asset Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Magellan Asset Management sold 980 Eli Lilly shares in Q4 2024, an estimated $868K.
  • Magellan Asset Management first reported a position in Eli Lilly in Q4 2017 and held it in 6 quarters.
  • Magellan Asset Management's Eli Lilly position peaked at $895K in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Magellan Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.